EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Gestational Exposure to Valproate and Autism Spectrum Disorder or Attention‐Deficit/Hyperactivity Disorder in Offspring: Systematic Review and Meta‐Analysis

Chittaranjan Andrade iD, Natarajan Varadharajan iD, Sharmi Bascarane, Akshayee Kale, Jilisha Gnanadhas, Vikas Menon iD

Acta Psychiatrica Scandinavica · 2025-06 · 151 (6) · 668-679

DOI: 10.1111/acps.13797 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Acta Psychiatrica Scandinavica, online erschienen am 09.03.2025. Verfasst von Chittaranjan Andrade und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka,…. Hauptthemen laut MEDLINE: Valproic Acid, Autism Spectrum Disorder, Attention Deficit Disorder with Hyperactivity, Prenatal Exposure Delayed Effects. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Gestational exposure to valproate has been associated with a wide range of adverse pregnancy outcomes, including major congenital malformations in offspring. However, to date, no meta‐analysis has comprehensively examined the risk of autism spectrum disorder (ASD) and attention‐deficit/hyperactivity disorder (ADHD) in children gestationally exposed to valproate.

Methods

We searched MEDLINE, Embase, and Scopus from inception until 15 May 2024 for relevant English‐language articles. Primary outcomes of interest were the risk of ASD and ADHD, two independent primary outcomes, in children exposed to valproate anytime during pregnancy relative to unexposed children. Secondary outcomes were trimester‐wise analyses of risk. We used a random effects model to pool the overall and trimester‐wise hazard ratios (HRs) and obtained 95% confidence intervals (CIs), separately for the risks of ASD and ADHD. Study quality was assessed using the Joanna Briggs Institute (JBI) critical appraisal checklist.

Results

Eight cohort studies (pooled N = 6,033,300) met our search criteria. Anytime gestational exposure to valproate was associated with a large increase in the risk of ASD (adjusted HR [aHR], 3.10; 95% confidence interval [CI], 2.24–4.28; N = 1,841,198) and a modest increase in the risk of ADHD (aHR, 1.62; 95% CI, 1.30–2.01; N = 24,295). The findings in sensitivity analyses for both outcomes were generally consistent with those of the main analyses. Notably, anytime gestational exposure to high‐dose valproate (> 1.0 to 1.1 g/day) was associated with a substantially elevated risk of ASD (aHR, 6.32; 95% CI, 3.12–12.80, N = 1,719,825). Likewise, in monotherapy (aHR, 4.21; 95% CI, 2.97–5.95; N = 1,745,253) and discordant sibling pair (aHR, 6.42; 95% CI, 2.02–20.42; N = 1133) analyses, the risk of ASD was substantially elevated.

Conclusion

Gestational exposure to valproate was associated with an increased risk of ASD and ADHD; the risks for ASD were greater at doses ≥ 1000 mg/day. These findings add to the literature that strongly discourages the use of valproate by women of childbearing age, especially during pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Valproic AcidAutism Spectrum DisorderAttention Deficit Disorder with HyperactivityPrenatal Exposure Delayed EffectsAnticonvulsantsHumansPregnancyFemaleChild

Stichwörter der Autor:innen

attention‐deficit/hyperactivity disorderautism spectrum disordergestational exposureneurodevelopmental disorderpregnancyvalproate

Substanzen

Valproic AcidAnticonvulsants

Autor:innen und Institutionen

  • Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India.
  • Department of Psychiatry, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.
  • Department of Psychiatry, Sri Venkateshwaraa Medical College Hospital & Research Centre, Puducherry, India.

ORCID-Profile: Chittaranjan Andrade, Natarajan Varadharajan, Vikas Menon

Zitieren

APA

Andrade, C., Varadharajan, N., Bascarane, S., Kale, A., Gnanadhas, J., & Menon, V. (2025). Gestational Exposure to Valproate and Autism Spectrum Disorder or Attention‐Deficit/Hyperactivity Disorder in Offspring: Systematic Review and Meta‐Analysis. Acta Psychiatrica Scandinavica, 151(6), 668-679. https://doi.org/10.1111/acps.13797

Vancouver

Andrade C, Varadharajan N, Bascarane S, Kale A, Gnanadhas J, Menon V. Gestational Exposure to Valproate and Autism Spectrum Disorder or Attention‐Deficit/Hyperactivity Disorder in Offspring: Systematic Review and Meta‐Analysis. Acta Psychiatrica Scandinavica. 2025;151(6):668-679. doi:10.1111/acps.13797

BibTeX
@article{Andrade2025,
  author = {Andrade, Chittaranjan and Varadharajan, Natarajan and Bascarane, Sharmi and Kale, Akshayee and Gnanadhas, Jilisha and Menon, Vikas},
  title = {Gestational Exposure to Valproate and Autism Spectrum Disorder or Attention‐Deficit/Hyperactivity Disorder in Offspring: Systematic Review and Meta‐Analysis},
  journal = {Acta Psychiatrica Scandinavica},
  year = {2025},
  volume = {151},
  number = {6},
  pages = {668--679},
  doi = {10.1111/acps.13797}
}
Kostenlos starten →